Non-Small Cell Lung Cancer: Challenge and Improvement of Immune Drug Resistance

Non-Small Cell Lung Cancer: Challenge and Improvement of Immune Drug Resistance

Lung cancer is the leading cause of cancer deaths in the world. At present, immunotherapy has made a great breakthrough in lung cancer treatment. A variety of immune checkpoint inhibitors have been applied into clinical practice, including antibodies targeting the programmed cell death-1, programmed...

Full description

Bibliographic Details
Main Authors: Fanming Kong, Ziwei Wang, Dongying Liao, Jinhui Zuo, Hongxia Xie, Xiaojiang Li, Yingjie Jia
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer
immunotherapy
drug resistance
strategy
biomarkers
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.739191/full

Similar Items

Similar Items